Drug scandal exposes French regulators to public ire

Abstract

Four of the UK’s leading healthcare industry associations, encompassing the pharmaceutical, biotechnology, medical device and diagnostic industries, are joining forces under a new initiative called LifeSciencesUK. Launched at the beginning of January, LifeSciencesUK aims to help strengthen and grow the UK life science sector for the benefit of both patients and the UK economy as a whole. The four founding members are the Association of British Healthcare Industries, the Association of the British Pharmaceutical Industry, the BioIndustry Association and the British In Vitro Diagnostics Association. The new initiative came out of the realization that the four associations were collaborating more and more on certain topics. This type of collaboration has imtensified ever since the formation of the UK’s Office for Life Sciences in 2009, which provided them all with the same main point of contact within the UK government. Drug scandal exposes French regulators to public ire

DOI: 10.1038/nm0211-144a

Cite this paper

@article{Casassus2011DrugSE, title={Drug scandal exposes French regulators to public ire}, author={Barbara Casassus}, journal={Nature Medicine}, year={2011}, volume={17}, pages={144-144} }